Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IV Endometrial Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02020707
What this trial is testing

Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers

Who this might be right for
Cervical AdenocarcinomaCervical AdenosarcomaCervical Adenosquamous Carcinoma+45 more
Mayo Clinic 43
Large-scale testing (Phase 3)UnknownNCT02065687
What this trial is testing

Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Serous Adenocarcinoma+9 more
Gynecologic Oncology Group 469
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07634601
What this trial is testing

Elacestrant With Everolimus for the Treatment of Recurrent Advanced or Metastatic ER-Positive Endometrial Cancer

Who this might be right for
Advanced Endometrial CarcinomaMetastatic Endometrial CarcinomaRecurrent Endometrial Carcinoma+2 more
Jonsson Comprehensive Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT00085332
What this trial is testing

Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer)

Who this might be right for
Endometrial Cancer
Gynecologic Oncology Group
Early research (Phase 1)Study completedNCT00003548
What this trial is testing

Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity

Who this might be right for
Cancer
NYU Langone Health 20
Testing effectiveness (Phase 2)Study completedNCT00006377
What this trial is testing

Doxorubicin, Paclitaxel, and Carboplatin in Treating Patients With Primary Stage III, Stage IV, or Recurrent Endometrial Cancer

Who this might be right for
Endometrial Cancer
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Looking for participantsNCT06533332
What this trial is testing

Trial of ERX-315 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorMetastatic Breast CancerMetastatic Ovarian Cancer+3 more
EtiraRx Australia Pty Ltd 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT03367741
What this trial is testing

Cabozantinib S-malate and Nivolumab in Treating Patients With Advanced, Recurrent, or Metastatic Endometrial Cancer

Who this might be right for
Advanced Endometrial CarcinomaMetastatic Endometrial CarcinomaRecurrent Endometrial Carcinoma+2 more
National Cancer Institute (NCI) 82
Not applicableWithdrawnNCT07226102
What this trial is testing

Virtual Mental Health Intervention to Address Fear of Progression for Women With High Risk or Stage III-IV Gynecologic or Breast Cancer

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Endometrial Carcinoma+10 more
City of Hope Medical Center
Not applicableEnded earlyNCT05891197
What this trial is testing

A Biomarker Screening Protocol for Participants With Solid Tumors

Who this might be right for
Triple Negative Breast CancerNon-small Cell Lung CancerNon Small Cell Lung Cancer+19 more
Lyell Immunopharma, Inc. 10
Early research (Phase 1)Looking for participantsNCT07755436
What this trial is testing

Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.

Who this might be right for
Ovarian CancerEndometrial CancerPlatinum-resistant Ovarian Cancer (PROC)+2 more
ArriVent BioPharma, Inc. 180
Large-scale testing (Phase 3)Study completedNCT00006011
What this trial is testing

Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Adenosquamous CarcinomaEndometrial Clear Cell Adenocarcinoma+3 more
Gynecologic Oncology Group 659
Testing effectiveness (Phase 2)UnknownNCT00003135
What this trial is testing

Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer

Who this might be right for
Breast CancerCervical CancerEndometrial Cancer+1 more
The University of Texas Health Science Center, Houston 34
Early research (Phase 1)Study completedNCT00659568
What this trial is testing

Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma

Who this might be right for
Breast CancerEndometrial CancerKidney Cancer+3 more
London Health Sciences Centre 28
Large-scale testing (Phase 3)Study completedNCT01767155
What this trial is testing

Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer

Who this might be right for
Endometrial Cancer
AEterna Zentaris 511
Large-scale testing (Phase 3)Study completedNCT00063999
What this trial is testing

Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer

Who this might be right for
Recurrent Uterine Corpus CarcinomaStage IIIA Uterine Corpus Cancer AJCC v7Stage IIIB Uterine Corpus Cancer AJCC v7+3 more
GOG Foundation 1,381
Early research (Phase 1)Study completedNCT01198184
What this trial is testing

Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 and Temsirolimus in Treating Patients With Advanced Solid Tumors

Who this might be right for
Endometrial Papillary Serous CarcinomaRecurrent Endometrial CarcinomaRecurrent Renal Cell Cancer+5 more
National Cancer Institute (NCI) 18
Early research (Phase 1)Study completedNCT00287885
What this trial is testing

Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer

Who this might be right for
Cervical CancerEndometrial CancerFallopian Tube Cancer+5 more
Masonic Cancer Center, University of Minnesota 18
Not applicableLooking for participantsNCT07062016
What this trial is testing

Molecular and ctDNA Characterization of High-Risk Endometrial Cancer

Who this might be right for
Endometrial CarcinomaEndometrial High Grade Endometrioid AdenocarcinomaStage II Endometrial Cancer+2 more
Mayo Clinic 100
Early research (Phase 1)Study completedNCT00408655
What this trial is testing

Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Tumors

Who this might be right for
Ovarian SarcomaOvarian Stromal CancerRecurrent Endometrial Carcinoma+9 more
National Cancer Institute (NCI) 38
Next Page